Introducing solutions for reading important information such as the concentration, labeling, stability, and viscosity of antibody-drug conjugates from rare samples.
ADC (Antibody-Drug Conjugate) is a biopharmaceutical that is attracting attention due to its pharmacological activity and the excellent specificity of antibodies. However, the characterization of ADCs is very challenging due to the rarity of samples and their tendency to aggregate. In this webinar, we will explain how to obtain important information such as the concentration, labeling, stability, and viscosity of mAbs and their conjugates from just a few microliters of sample, along with actual data to demonstrate the evaluation of ADC characteristics. ■ Date and Time: June 16 (Friday) 14:00~ ■ Speaker: Yukinori Ooshiro, Field Application Scientist, Unchained Labs, Inc. ■ Register here: https://unchainedlabs.zoom.us/webinar/register/5816780852848/WN__LZqwPKFTvy2KTYnajByqg
Inquire About This Product
catalog（10）
Download All Catalogs
Company information
Unchained Labs is a company headquartered in Silicon Valley, California, that provides next-generation life science tools. - A lineup of automation devices for biopharmaceutical research, gene therapy, and organic synthesis - Founded in 2015 - Locations in California, New Jersey, Boston, the UK, Brussels, Germany, Shanghai, and Japan - Established a Japanese subsidiary in July 2017
![[Webinar] Let's Tackle the Stability and Viscosity of Biopharmaceuticals](https://image.mono.ipros.com/public/product/image/2b4/2000850117/IPROS42050443695145500861.png?w=280&h=280)
